Apple today launched its atrial fibrillation history feature for Apple Watch in mainland China. Since 2022, Apple Watch in the U.S. has supported AFib History, which allows users diagnosed with atrial ...

Apple has launched AFib History on Apple Watch in mainland China, giving diagnosed users a new way to track heart rhythm patterns over time.

Compared with regular checks in primary care, continuous ECG monitoring revealed more asymptomatic older people with hypertension as having atrial fibrillation (Afib), the SCREEN-AF trial showed. The ...

Please provide your email address to receive an email when new articles are posted on . Two studies found that mass screening for atrial fibrillation in older adults does not reduce stroke. In one ...

Screening for atrial fibrillation (Afib) -- whether with ECG in office or via a wearable device -- cannot be recommended for middle age and older adults without symptoms. So reaffirmed the U.S.

Apple has landed a new FDA clearance for an updated version of its ECG feature, allowing the tool to add a category called A-Fib with high heart rate. This comes a little over two years after Apple ...

On Friday, the Food and Drug Administration granted another 510(k) clearance to iRhythm Technologies for its AI-powered software system designed for use with Verily’s irregular pulse tracking watch.

Garmin has announced a new ECG app for AFibVenu 2 Plus smartwatch users. This app is cleared by the U. S. Food and Drug Administration (FDA) and allows anyone with the Venu 2 Plus to record their ...

Mass screening for atrial fibrillation using ECG together with heart failure biomarker does not prevent ischaemic stroke or systemic embolism (blood clot) in older adults aged 75-76 years over 5 years ...

A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrial fibrillation (or AFib) - an irregular, fast heartbeat that is ...

From the Oura Ring to the Apple Watch to the Google Pixel — here's what the science really says about the accuracy of their health data ...

People don't buy consumer wearables just to count steps anymore. They want early warnings, useful health signals, and features they can trust.